Breaking News
December 13, 2018 - Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of Fintepla (ZX008) in Dravet Syndrome
December 13, 2018 - BCR ABL Genetic Test: MedlinePlus Lab Test Information
December 13, 2018 - Caffeinated beverages during pregnancy linked to lower birth weight babies
December 13, 2018 - Stanford Medicine Health Trends Report examines opportunity to democratize health care
December 13, 2018 - Obsessive-compulsive disorder may protect individuals from obesity
December 13, 2018 - Scientists investigate how a painful event is processed in the brain
December 13, 2018 - Genetic study reveals new insights into underlying causes of moderate-to-severe asthma
December 13, 2018 - Vitamin C supplementation for pregnant smokers may reduce harm to infants’ lungs
December 13, 2018 - New study reveals yin-yang personality of dopamine
December 13, 2018 - Long-term Benefit of Steroid Injections for Knee Osteoarthritis Challenged
December 13, 2018 - Adding new channels to the brain remote control
December 13, 2018 - In the Spotlight: A different side of neuroscience
December 13, 2018 - Medical Marvels: Using immunotherapy for melanoma that spread to the brain
December 13, 2018 - Puzzles do not keep dementia away finds study
December 13, 2018 - New mouse model shows potential for rapid identification of promising muscular dystrophy therapies
December 13, 2018 - Study reveals urban and rural differences in prenatal exposure to essential and toxic elements
December 13, 2018 - New collaborative partnership in quest of novel antibiotics
December 13, 2018 - Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages
December 13, 2018 - AHA Scientific Statement: Low Risk of Side Effects for Statins
December 13, 2018 - What Is Acute Flaccid Myelitis?
December 13, 2018 - How bereaved people control their thoughts without knowing it
December 13, 2018 - Health care democratization underway, according to 2nd annual Stanford Medicine Health Trends Report | News Center
December 13, 2018 - Going Beyond a Single Color
December 13, 2018 - London-based startup launches ‘thedrug.store’ aiming to clean up CBD industry
December 13, 2018 - Loss of tight junction barrier protein results in gastric cancer development
December 13, 2018 - Novel way to efficiently deliver anti-parasitic medicines
December 13, 2018 - RKI publishes new data on disease prevention and utilization of medical services
December 13, 2018 - High-tech, flexible patches sewn into clothes could help to stay warm
December 13, 2018 - The CCA releases three reports on requests for medical assistance in dying
December 13, 2018 - Restoring Hair Growth on Scarred Skin? Mouse Study Could Show the Way
December 13, 2018 - Probiotic use may reduce antibiotic prescriptions, researchers say
December 13, 2018 - Drug repositioning strategy identifies potential new treatments for epilepsy
December 13, 2018 - Chronic rhinitis associated with hospital readmissions for asthma and COPD patients
December 13, 2018 - Food poisoning discovery could save lives
December 13, 2018 - Cloned antibodies show potential to treat, diagnose life-threatening fungal infections
December 13, 2018 - Exercise may reduce colorectal cancer risk after weight loss
December 13, 2018 - Russian scientists create hardware-information system for brain disorders treatment
December 13, 2018 - Moderate alcohol consumption linked with lower risk of hospitalization
December 13, 2018 - Nurturing Healthy Neighborhoods | NIH News in Health
December 13, 2018 - Rise in meth and opioid use during pregnancy
December 13, 2018 - Researchers gain new insights into pediatric tumors
December 13, 2018 - FSU study finds racial disparity among adolescents receiving flu vaccine
December 13, 2018 - Study investigates attitudes toward implementation of ‘sex as a biological variable’ policy
December 13, 2018 - Drug cocktail induces cancer cell death by switching off energy supply
December 13, 2018 - Baculovirus virion completely eliminates liver-stage parasites in mouse model
December 13, 2018 - Researchers create noninvasive technology that detects when nerve cells fire
December 13, 2018 - Allen Institute for Immunology to partner with CU Anschutz to understand dynamics of human immune system
December 13, 2018 - Inability to do daily living tasks delays discharge of mental health patients
December 13, 2018 - Treating patients with hypertension induced albuminuria
December 13, 2018 - New substance could improve efficacy of established breast cancer treatments
December 13, 2018 - Scientists develop new stem cell line to study conversion of stem cells into muscle
December 13, 2018 - Re-programming the body’s energy pathway boosts kidney self-repair
December 13, 2018 - Research findings could help improve treatment of anxiety and post-traumatic stress disorders
December 13, 2018 - The Microbiome Movement announce Microbiotica as official industry partner
December 13, 2018 - New study reveals potential benefits of cEEG monitoring for infant ICU patients
December 13, 2018 - Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer
December 13, 2018 - International investigators fight against the negative campaign on benzodiazepines
December 13, 2018 - Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders
December 13, 2018 - FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections
December 13, 2018 - Are scientists studying the wrong kind of mice?
December 13, 2018 - Computer memory: A scientific team builds a virtual model of a key brain region
December 13, 2018 - Visual inspection alone is insufficient to diagnose skin cancer
December 13, 2018 - Paternal grandfather’s access to food associated with grandson’s mortality risk
December 13, 2018 - Our brain senses angry voices in a flash, study shows
December 13, 2018 - PM2.5 Exposure Linked to Asthma Rescue Medication Use
December 13, 2018 - Can’t exercise? A hot bath may help improve inflammation, metabolism, study suggests
December 13, 2018 - Can artificial intelligence help doctors with the human side of medicine?
December 13, 2018 - Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain
December 13, 2018 - NIH offers support for HIV care and prevention research in the southern United States
December 12, 2018 - Activating brain region could revive the urge to socialize among opioid addicts
December 12, 2018 - Relationship impairment appears to interfere with seeking mental health treatment in men
December 12, 2018 - Sleep, Don’t Cram, Before Finals for Better Grades
December 12, 2018 - Effective treatments for urticarial vasculitis
December 12, 2018 - Gun violence is a public health issue: One physician’s story
December 12, 2018 - The Science of Healthy Aging
December 12, 2018 - Yes to yoghurt and cheese: New improved Mediterranean diet
December 12, 2018 - Researchers uncover a number of previously unknown insecticide resistance mechanisms
December 12, 2018 - Regulating the immune system’s ‘regulator’
December 12, 2018 - In breaking bad news, the comfort of silence
December 12, 2018 - Study finds upward link between alcohol consumption and physical activity in college students
To better treat COPD, scientists look to tailored approaches for deadly lung disease

To better treat COPD, scientists look to tailored approaches for deadly lung disease

image_pdfDownload PDFimage_print
A normal mouse lung (left) and one with abnormal activation of hedgehog. Credit: Tien Peng

Valerie Chang kept waking up breathless in the middle of the night. As a regular swimmer and non-smoker, she figured it was a fluke, a remnant of her childhood asthma, perhaps.

But after a lung test, doctors told her that she had chronic obstructive pulmonary disease (COPD); her lung function was only 30 percent and she had done irreversible damage to her lungs. Unfortunately, they said, there was nothing they could do to improve her lung function, and she would likely need a transplant in a year.

Eighteen years later, Chang’s original lungs are still intact and her emphysema and asthma are under control, but she’s had to go through dozens of medications and multiple doctors to get there. As a non-smoker, Chang doesn’t fit the typical profile of someone with COPD, but the revolving door of drugs – and her frustration around it – are not atypical.

“Most of the treatments for COPD are just symptomatic, and that’s really not that comforting – especially if you’re 42, which I was when I was diagnosed, and you have young children and you are wondering if you’ll be around to watch them grow up,” says Chang, who is now being treated at UC San Francisco by professor of medicine Steven Lazarus, MD.

COPD is the third-leading cause of death in the world. And though treatments exist to improve the symptoms of COPD, as in the case of Chang, there is no way to slow the progression of the condition or cure it.

The main difficulty in finding a cure is COPD’s heterogeneous nature – the disease can be thought of as an umbrella term for various symptoms, the most prominent being inflammation of the small airways (bronchitis) and destruction of the air sacs, or alveoli, in the lungs (emphysema). There are also varying genetic and environmental risk factors for COPD, as well as differences in disease exacerbation and progression.

To develop novel therapies to treat specific subtypes of COPD, and potentially even to reverse some of the symptoms, scientists at UCSF are taking a precision medicine approach to the disease. They are also searching for improved biomarkers that can match treatments to the patients who will benefit from them the most.

Fighting Inflammation

The first intervention for COPD is typically to get patients to stop smoking cigarettes, since that is the primary cause of the condition in the United States, where 16 million people have been diagnosed with the disease. Chronic exposure to cigarette smoke can trigger inflammation and scarring in the airways. Ordinarily, healthy organs absorb scar tissue over time and return to normal, but in COPD the damage to the airways remains and lung function can continue to decline even after people quit smoking.

Regardless of the root cause, the current treatment for airway inflammation is steroid inhalers like the ones used for asthma, but these drugs often don’t work in COPD. Stephen Nishimura, MD, Chief of Pathology at UCSF, says that one reason for this may be that the traditional pathways involved in inflammation don’t hold true for COPD. “We need to study and target other inflammatory pathways that are specific to COPD and could possibly have a greater therapeutic benefit,” he says.

In his search for the source of inflammation, Nishimura turned to TGF-beta, a protein that is critical for immune function and the generation of scar tissue. When TGF-beta is activated in a cell it leads to the production of the inflammatory protein IL-17. Working in mice, Nishimura developed an antibody that was able to prevent the activation of TGF-beta specifically in the lung. By suppressing TGF-beta activation, the anti-body successfully blocked IL-17 inflammation, which in turn prevented scar tissue formation.

Nishimura is now working with a pharmaceutical company to bring the antibody to patients. However, as not all COPD patients suffer from airway scarring, an important next step is to identify which patients have the symptom and are therefore most likely to benefit from the therapy.

“We have an idea of how this pathway might be involved in airway disease in humans, but we lack a critical piece of puzzle: how to identify patients who should have the treatment,” Nishimura says. “We need to look for biomarkers that predict which patients are going to have this type of inflammatory response.”

Searching the Microbiome

One biomarker that could help to indicate what’s happening in the lung and categorize the different subtypes of COPD is the lung’s microbiome.

“A lot of our work focuses on trying to identify subgroups of patients with different responses in the lung. If we can find subsets of patients that are going to be more responsive to therapies, doctors can tailor their treatment options accordingly,” said Stephanie Christenson, MD, an assistant professor of medicine at UCSF.

Christenson is particularly interested in exacerbations of COPD, a worsening of symptoms that is typically treated with steroids or antibiotics. However, doctors often don’t know why an exacerbation occurred – whether it was due to a viral or bacterial infection, pollution, or an unknown cause. The root of an exacerbation makes a big difference in how you treat it; you don’t want to give a patient antibiotics if they have a viral infection.

Changes to the microbiome during an exacerbation and, perhaps even more importantly, how the lung responds may hold the answer. Christenson is analyzing phlegm samples that were collected from patients before, during and after an exacerbation to see if she can subgroup them based on how their microbiome changed. She can track gene expression in the lung to see changes in inflammation, as well as the presence of a virus or bacterial infection.

With this information, she’s been able to identify different types of inflammation based on immune responses in the lung, which can then be matched to treatments. For example, type 2 inflammation is an asthma-like inflammatory response that can be managed with inhaled steroids, while inflammation from IL-17 (one of the proteins affected by Nishimura’s antibody) is thought of as a response to bacteria and doesn’t respond as well to inhaled steroids.

“A lot of times we just throw everything at these patients – we’ll try giving patients both an antibiotic and a steroid – but those things come with risks,” Christenson says. “If we can identify biomarkers that tell us whether a patient has a change in their gene expression that would be solved by giving them a steroid, then those are the patients we should give steroids to. On the other hand, if we can clearly identify a bacterial infection, we should be treating it with antibiotics.”

Looking to the Genes

Another way to distinguish between subclasses of COPD is a patient’s genes. UCSF assistant professor of medicine Tien Peng, MD, is using genetic information about COPD to guide the development of novel treatments for the disease.

“There are a lot of smokers, but only a relatively small subset of them develop COPD with emphysema, so there must be some underlying genetic predisposition for those people,” Peng says.

Over the last decade, genome-wide studies have identified several changes within different parts of the genome that might predict who is at risk for emphysema. One of the cellular pathways that might be genetically modified is called “hedgehog.” The hedgehog pathway plays an important role in how stem cells function in the lung. It is typically activated in cells around the airways of the lung but not lower down in the air sacs, or alveoli.

In a recent article in the Journal of Clinical Investigation, Peng reports that abnormal activation of hedgehog in cells in the alveoli causes emphysema in mice by impeding the ability of lung stem cells to regenerate damaged alveoli.

“Stem cells are critical to maintaining the structure of an organ. We show that activation of hedgehog results in fewer stem cells because the cells won’t renew, and that may explain the loss of air sac structures in emphysema,” Peng says. “This is a new way of thinking about emphysema as a disease of aberrant regeneration or loss of stem cell capacity, rather than simply as a disease of inflammation.”

Peng is currently exploring various ways to modify hedgehog signaling in the lung to improve stem cell function, with the goal of developing a new therapy for COPD patients with emphysema.

No One-Size-Fits-All

In a heterogeneous condition such as COPD, scientists’ pursuit of specialized research to advance the field as a whole is key, since one drug is not going to treat every subtype of the disorder, and attempting a blanket clinical trial would surely result in failure.

“A lot of people are working on COPD from all different angles,” says Nishimura. “Our hope is that the other arms are keeping up progress so that when a drug is ready, we can identify and deliver it to the patients who would benefit the most.”


Explore further:
Inhaled steroids may increase risk of nontuberculous mycobacteria lung infections

More information:
Chaoqun Wang et al. Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype, Journal of Clinical Investigation (2018). DOI: 10.1172/JCI99435

Journal reference:
Journal of Clinical Investigation

Provided by:
University of California, San Francisco

Tagged with:

About author

Related Articles